Solstein Capital, LLC Charles River Laboratories International, Inc. Transaction History
Solstein Capital, LLC
- $177 Million
- Q1 2025
A detailed history of Solstein Capital, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Solstein Capital, LLC holds 714 shares of CRL stock, worth $81,867. This represents 0.06% of its overall portfolio holdings.
Number of Shares
714
Previous 714
-0.0%
Holding current value
$81,867
Previous $131,000
18.32%
% of portfolio
0.06%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding CRL
# of Institutions
698Shares Held
50.6MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$706 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$583 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$250 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$207 Million0.79% of portfolio
-
Allspring Global Investments Holdings, LLC1.77MShares$203 Million0.5% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $5.83B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...